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Abstract
Metabolomics studies of disease conditions related to chronic alcohol consumption provide
compelling evidence of several perturbed metabolic pathways underlying the pathophysiology
of alcoholism. The objective of the present study was to utilize proton nuclear magnetic reso-
nance (1H-NMR) spectroscopy metabolomics to study the holistic metabolic consequences of
acute alcohol consumption in humans. The experimental design was a cross-over interven-
tion study which included a number of substances to be consumed—alcohol, a nicotinamide
adenine dinucleotide (NAD) supplement, and a benzoic acid-containing flavoured water vehi-
cle. The experimental subjects—24 healthy, moderate-drinking young men—each provided
six hourly-collected urine samples for analysis. Complete data sets were obtained from 20 of
the subjects and used for data generation, analysis and interpretation. The results from the
NMR approach produced complex spectral data, which could be resolved sufficiently through
the application of a combination of univariate and multivariate methods of statistical analysis.
The metabolite profiles resulting from acute alcohol consumption indicated that alcohol-
induced NAD+ depletion, and the production of an excessive amount of reducing equivalents,
greatly perturbed the hepatocyte redox homeostasis, resulting in essentially three major met-
abolic disturbances—up-regulated lactic acid metabolism, down-regulated purine catabolism
and osmoregulation. Of these, the urinary excretion of the osmolyte sorbitol proved to be
novel, and suggests hepatocyte swelling due to ethanol influx following acute alcohol con-
sumption. Time-dependent metabolomics investigations, using designed interventions,
provide a way of interpreting the variation induced by the different factors of a designed exper-
iment, thereby also giving methodological significance to this study. The outcomes of this
approach have the potential to significantly advance our understanding of the serious impact
of the pathophysiological perturbations which arise from the consumption of a single, large
dose of alcohol—a simulation of a widespread, and mostly naive, social practice.
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Introduction
The use of metabolomics in intervention, or challenge, studies greatly enhances the holistic
understanding of the effects of single, or combined, consumed substances on metabolic path-
ways [1,2,3]. In this paper, we present the experimental design and outcome of an intervention
study, which included a number of interventions: (1) vehicle only—commercial flavoured
water containing sodium benzoate as preservative [3]; (2) a defined acute dose of alcohol, con-
sumed alongside the vehicle; (3) an NAD supplement, taken one hour prior to the study, fol-
lowed by consumption of the vehicle; and (4) the NAD supplement, followed by consumption
of the vehicle and the alcohol dose. Alcohol oxidation by alcohol dehydrogenase (ADH) and
aldehyde dehydrogenase (ALDH) results in the reduction of oxidized NAD (NAD+) to its
reduced form (NADH), thereby generating a highly reduced cytosolic environment in hepato-
cytes. An increased NADH:NAD+ ratio has been described to influence several metabolic pro-
cesses, resulting in, amongst others, decreased glycolysis [4], reduced Krebs cycle [5,6], and
decreased gluconeogenesis [6,7]. The use here of NAD as a supplement is based on a perceived
view that it has a therapeutic capacity if taken prior to alcohol consumption; the theory being
that it supplements alcohol-induced NAD+ depletion.
The data set of the present study was generated from longitudinal (urine samples, collected
hourly over a five-hour period), multi-subject (several experimental participants) and multi-
group (in this case four, separate interventions) measurements, and expressed as multivariate
data—numerous variables generated and identified through a metabolomics approach utiliz-
ing 1H-NMR spectroscopy. The main aim of the investigation was to determine the effect of
acute (a single dose indigested in a short time) alcohol consumption, as well as the potential
effect of an NAD supplement on the resulting metabolite profile. Several metabolomics studies
have been reported on the pathophysiological consequences of chronic consumption and alco-
holism in humans [8,9,10,11], as well as on chronic intragastric alcohol feeding of rodents, fol-
lowed by mass spectrometric based metabolite profiling [12,13]. The metabolomics technique
has been applied for global metabolite profiling using GC–MS [14,15], in several LC–MS stud-
ies [12,13,16,17], as well as in untargeted studies using 1H-NMR spectroscopy (examples
hereof are summarized in Table 1). 1H-NMR spectroscopy is a robust method with broad
metabolite-class coverage (albeit with limited sensitivity), and is well suited for the diverse
metabolomics studies listed in Table 1 using rodents [18,19,20,21,22], selected human volun-
teers at risk for cardiovascular diseases [23], and population-based cohorts [24]. With the
exception of the study by Bradford et al. [19], all the studies listed in Table 1 used serum or tis-
sue material as the samples for the generation of the metabolite data. Here we report on an
untargeted NMR metabolomics intervention study on acute alcohol consumption, which
expands the limited data on alcohol-induced metabolic profiling in humans. This study fol-
lowed a non-invasive sampling procedure (hourly-collected urine samples) which is ideal for
generating the untargeted 1H-NMR-based metabolic profiles required for the longitudinal
experimental design. As a biological waste material, urine is the biofluid of choice [25] to
reflect the metabolic breakdown products following acute alcohol consumption, as well as any
potential by-products derived from the gut microbiome, which has been shown to be impor-
tant in several alcohol-related studies [14,16,26]. The data pre-processing applied to the spec-
tral data in the present study are comparable to the approaches applied in the studies listed in
Table 1, albeit with minor differences.
The statistical methods used in the intervention studies listed in Table 1 all use a pre vs post
approach—multivariate model-based analysis (PCA, PLS–DA, OPLS and ANOVAs) of the
data was performed to determine the metabolites responsible for the separation of the control
(“pre”) versus the alcohol-treated (“post”) groups. Analysis of the data set from the present
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Table 1. A summary of the experimental designs, data analysis approaches and main metabolic conclusions of some NMR-based ethanol administration studies.
Authors (year) &
Summary of design
Data pre-processing Statistical analysis Conclusion on metabolic observations
Nicolas et al (2008)
C: Sprague–Dawley rats (N = 5). S:
Serum and tissue. E: Single dose/
binge protocol. A: Untargeted
(1) Zero-filled. (2) Fourier transformed.
(3) Baseline corrected
D: Spectral bins. T: Mean centred. G: Pre
vs Post. U: t-test. M: PCA
A cycle of aborted gluconeogenesis
stimulated by the increased NADH/NAD
ratio but short-circuited by decreased
alanine levels during hepatic ethanol
metabolism.
Bradford et al (2008)
C: Male C57Bl/6J mice (N = 4). S:
Urine, serum and liver. E: Chronic:
7–36 g/kg/day; Fed ad libitum. A:
Untargeted
(1) Spectra phased. (2) Baseline
corrected. (3) Normalized to the sum of
all integrals set to 1000
D: Spectral bins. T: Pareto scaled. G: Pre
vs Post. U: t-test. M: PCA & OPLS
Energy utilization is important in
understanding the pathogenesis of alcohol
induced liver injury, with acetylglutamine,
n-acetylglycine and taurine potential novel
non-invasive markers of alcohol
consumption and oxidative stress.
Masuo et al (2009)
C: Female Fisher rats (N = 5). S: Liver
and brain. E: Chronic: 10 mo 15%
Sake; Fed ad libitum. A: Untargeted
(1) Spectra normalize to total integral
area. (2) Referenced to Na-TMS-tetra-
1H-propionate
D: Spectral bins. T: Pareto scaled. G: Pre
vs Post. U: t-test. M: PCA & PLS–DA
In liver: An attenuation of mitochondrial
function; In brain: (1) Perturbed amino
acids (Increased and decreased); and (2)
Decreased N-acetyl-aspartate, taurine and
GABA. Chronic Sake intake may cause
alterations in the intoxicated body but also
in the next generation.
Fernando et al (2010)
C: Male Fischer rats (N = 344). S:
Plasma and liver. E: Chronic: 5%
alcohol diet. A: Lipidome
(1) Spectra manually phased. Referenced
to TMS. (2) Spectra divided into equal
bins of 0.01 ppm width. (3) Baseline
corrected
D: Spectral bins. T: Auto scaled. G: Pre vs
Post. U: t-test. M: Hierarchical clustering
& PCA
Alcohol consumption alters metabolism of
cholesterol, triglycerides and phospholipids
that could contribute to the development of
fatty liver and indicates that fatty liver
precedes oxidative stress and inflammation.
Yoseph et al (2013)
C: Male FVB/N mice (N: 8–9). S:
Pancreatic tissue. E: Chronic; Fed ad
libitum with increased interventions.
A: Untargeted/Focus: Pancreatic
metabolome
(1) Spectra phased. (2) Baseline
corrected. (3) Spiking experiments to
validate suspected metabolites identified
in the spectra.
D: 52 Metabolites (mM). T: Variance
scaled. G: Pre vs Post. U: t-test & MW
test. M: PLS–DA & One-way ANOVA
(Tukey post-test)
Pancreatic metabolome following chronic
alcohol intake indicates increased acetate,
adenosine, xanthine, acetoacetate,
3-hydroxybutyrate and betaine; and (2)
decreased cytidine, uracil, fumarate,
creatine phosphate creatine, and choline.
Mice with chronic alcohol ingestion have
increased mortality when encountered with
sepsis.
Va´zquez-Fresno et al (2012)
C: Males volunteers at risk (Age55;
N = 61). S: 24-hour urine. E:
Nutritional wine. A: Untargeted and
selected metabolites
Untargeted: (1) Spectra divided into
equal bins. (2) Profiling integration. (3)
Spectra phased. (4) Baseline corrected.
(5) Calibrated. Selected metabolites:
Chenomx NMR Suite 7.0 profiler
compared on: HMDB/BMRB/MMCD
and literature
D: Spectral bins. T: Pareto scaled. G: Pre
vs Post. U: t-test; Pearson’s correlation.
M: ANOVA & Fisher’s LSD
(1) Food metabolome: Mannitol (diet);
tartrate (wine intake). (2) Endogenous
modifications after wine consumption
indicated by branch-chain amino acids. (3)
Gut metabolites, 4-hydroxy phenylacetate
and hippurate
Wurtz et al (2016)
C: 3 population-based cohorts,
(meta-analysis N = 9778). S: Serum.
E: Habitual consumption. A:
Targeted lipids and 86 metabolic
measures
Automated NMR metabolite profiling:
Robotics-controlled and fully automated
with a capacity of about 150–180
samples in 24 h. Integrated
computational methods for the data-
driven systems biology approach to
biomedical research
D: Computational generated. T: Loge
transformed & SD Scaled. G: Cross-
sectional (i.e. 2 group comparisons). U:
Bonferroni method; t-test & MW test. M:
Linear regression (R-squared)
Prominent metabolic associations with
alcohol consumption include
monounsaturated fatty acids, omega-6 fatty
acids, glutamine, citrate and lipoprotein
particle size. Many of these cardiometabolic
biomarkers strongly associated with alcohol
intake as HDL cholesterol.
Irwin et al (the present study)
C: Healthy males (Age~22; N = 24).
S: Hourly urine (5 times). E: Acute
(1.5 g vodka/kg). A: Untargeted and
quantified metabolites
Normalized relative to the creatinine at
4.05 ppm. Baseline corrected– 50% zero-
filter. Batch comparisons using QC
samples
D: Spectral bins (excluding H2O region).
T: loge transformed; Auto-scaled. G:
Cross-over, time dependent matched
series. U: WR-test; ES; FC. M: Hierarchal
cluster; Multi-level PCA. The NAD-
effect: 2-way RM ANOVA
Aims: (1) Effect of vehicle consumption:
Irwin et al (2016) PLOS ONE. 11:e0167309.
(2) Impact of consumption of a single large
dose of alcohol (time dependence). (3)
Statistical analysis of quantified metabolites
following consumption. (4) Effect of NAD
supplementation. (5) Model of the
metabolite profile following acute alcohol
consumption
Abbreviations used in columns 1 and 3: C: Cases studied (experimental animals or humans); S: Samples used for metabolite identification; E: Ethanol exposure; A:
Approach for the generation of the variable or metabolite data; N: number of experimental cases studied; D: Data used for statistical analyses; T: Transformation and
scaling approach; G: Groups compared; U: Univariate analyses applied; M: Multivariate analyses applied.
Other abbreviations: ES: Effect Size; FC: Fold Change; ANOVA: Analysis of variance; MW: Mann-Whitney test; PCA: Principal Component Analysis; PLS-DA: Partial
Least Squares-Discriminant Analysis; RM: Repeated Measures; WC: Wilcoxon test.
https://doi.org/10.1371/journal.pone.0196850.t001
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study is theoretically complex and required methods specifically designed for longitudinal,
multi-subject, multi-group and multivariate data [27,28]. We accordingly generated a
matched-sample series through a cross-over study of participating subjects, collecting samples
over a distinct time frame. First, data from the “vehicle only” and “alcohol plus vehicle” inter-
ventions were compared at each time point to determine the impact of the consumption of a
single, large dose of alcohol. Next, the statistical analysis focused on the metabolic perturba-
tions due to the acute consumption of alcohol, measured over time. A shortlist of significantly
perturbed NMR spectral bins was compiled and quantified as relative concentrations for bio-
logical interpretation. Finally, the effect of NAD supplementation was evaluated for a select list
of biologically relevant metabolites.
Most remarkable in the present study was the highly increased presence of urinary sorbitol,
a response to alcohol consumption not observed in the studies listed in Table 1, nor previously
reported elsewhere. The other main metabolic observations that emanated from this NMR-
based intervention study was the increased levels of urinary lactic acid (indicated as a bio-
marker in two of the listed rodent studies) and hypoxanthine (not observed in the studies listed
in Table 1, but observed in another metabolomics study on patients with liver cirrhosis [11]).
Both these observations strongly support the view that the reduced cytosolic environment is
the primary metabolic consequence of acute alcohol consumption. Taken together, the meta-
bolic information acquired from this metabolomics study further underscores the view that
alcohol consumption is associated with severe risks and remains one of the world’s leading
health risk factors for disability, morbidity and mortality. This is succinctly expressed in the
2014 World Health Organization global status report on alcohol [29]: “Of all deaths worldwide,
5.9% are attributable to alcohol consumption; this is greater than, for example, the proportion of
deaths from HIV/AIDS (2.8%), violence (0.9%) or tuberculosis (1.7%)”.
Materials and methods
Chemicals and reagents
The substances used for the interventions reported here were: commercial flavoured water as
vehicle (aQuelle´ lemon-flavoured sparkling water, containing carbonated natural spring water;
fructose; citric acid; flavouring; sodium benzoate preservative; sodium cyclamate, aspartame,
acesulfame K non-nutritive sweeteners; and vitamin C– www.aquelle.co.za, product of South
Africa); commercial alcohol for consumption (Smirnoff No. 21 triple-distilled vodka: 43%
alcohol–product of South Africa); NAD (NAD ASSIST–product of Future Health, South
Africa); and commercial bottled water (Valpre´ still spring water, inorganic contents specified–
product of South Africa). The internal standard for the 1H-NMR analysis was trimethyl-
2,2,3,3-tetradeuteropropionic acid (TSP, sodium salt; Sigma Aldrich).
Experimental subjects and protocol
The participants in the intervention study consisted of a group of 24 medically confirmed
healthy males, of various ethnicities, between 20 and 24 years of age. All of the participants
were in a healthy, athletic condition, with weights in the 61–92 kg range. They were neither
alcohol addicts nor total abstainers, but confirmed their use of alcohol at a moderate social
level. No participants took any medication, all were asked to refrain from vitamins, minerals,
and other supplementation, and were requested to follow a similar dietary and lifestyle pattern
for the duration of the study. The complete protocol, described previously [3], was approved
by the Health Sciences Ethical Committee of North-West University (Ethical approval num-
ber: NWU-00045-12-S1) and conducted in accordance with guidelines for good clinical prac-
tice. The study was performed at the Health Clinic of the university, under the supervision of a
Metabolomics of acute alcohol consumption
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medical doctor as well as a nurse, and all participants could leave the premises only after
approval by the doctor.
The experiments were conducted on Saturday mornings between 08:00 and 12:00. All par-
ticipants had to abstain from breakfast and had to provide an early morning urine sample, col-
lected one hour before the start of the experiment (time –1). The participants were randomly
assigned to an intervention group until all 24 had participated in all four interventions (“vehi-
cle only”, “alcohol plus vehicle”, “vehicle plus NAD” and “vehicle plus alcohol and NAD”).
Owing to commitments of some participants, the experiments were performed over a period
of 7 consecutive Saturdays. However, three of the participants failed to participate in all four
interventions, and their samples were therefore excluded from the data generation process.
Through data analysis, one further participant was marked as an outlier in one of the interven-
tions, and was therefore also excluded from further analyses. Thus, the data generated were
based on the complete sets of information obtained from 20 participants.
The four interventions consisted of the consumption of: (1) 500 mL lemon-flavoured water
only, to measure the baseline effect of the vehicle; (2) 1.5 g vodka per kg body mass; (3) one
tablet containing 50 mg NAD; and (4) 1.5 g vodka per kg body mass plus 50 mg NAD. In all
three of the latter interventions, the substances were consumed with 500 mL flavoured water
as vehicle. NAD (where applicable) was taken one hour before the start of the experiment,
directly after collection of the first (time –1) urine sample. The dose and time schedule for con-
suming the alcohol (maximally five minutes) comply with established criteria to result in a tol-
erable but moderately severe level of acute alcohol intoxication [30]. All participants were
provided with 1.5 L pure spring water, which was the only substance that could be consumed
over the four-hour period of sample collection. Urine samples were collected at time 0, just
prior to consumption of the substances, followed by four further samples at 1, 2, 3 and 4 hours
thereafter, providing six samples in total from each participant for each of the four interven-
tions. All samples were treated, stored, prepared and analysed according to the protocol
described previously [3] and included in Sections A.1 and A.2 in S1 File. Although repeatabil-
ity and reproducibility are not major concerns in NMR analyses [31], the measurement design
included the use of pooled quality control (QC) samples to estimate any batch effect or other
interfering analytical aspect. The collected samples were analyzed in 24 separate batches, each
batch containing the 24 samples of a single subject and three QC samples. The batch analysis
order is given in Section A.1 in S1 File. The quality assurance results (given in Section A.3.2
and Figure A in S1 File) indicated that the QC samples clustered close together and therefore
no batch correction was required.
Uric acid does not have NMR-detectable protons at physiological pH, making it essentially
‘‘NMR invisible” [25]. Uric acid concentrations were therefore determined in each sample
individually on a ThermoFisher Scientific Clinica Chemistry Analyzer (type 863), using Ther-
moFisher Scientific Uric Acid Reagents (details on the analysis are included in Section B in S1
File).
Data analysis
The original NMR spectral data (referred to in Section C in S1 File and available in S2 File)
were subjected to pre-processing—data were normalized relative to the CH2 creatinine peak
(at 4.05 ppm), and very low values were replaced with zero, before performing a 50% zero-filter
(details in Section A.3.1 in S1 File). Further bin reduction, based on batch comparisons of the
coefficient of variation of the bins from the QC samples, yielded 289 bins for further analyses.
The resulting data were analysed along all dimensions in order to understand the metabolic
effect of the different interventions in time, as well as the differences between the participants,
Metabolomics of acute alcohol consumption
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even when considering a relatively homogeneous group such as the subjects involved in this
study. The analysis was performed on different cross-sections and blocks of the data tensor.
Univariate as well as multivariate methods were applied. Data were log transformed (natural
log with shift parameter equal to 1) and auto-scaled (per bin) prior to univariate (parametric
tests only) and multivariate analysis.
The first analysis aimed to shed light on the impact of the consumption of a single, large
dose of alcohol. To illustrate this effect, data from the “vehicle only” and “alcohol plus vehicle”
interventions were compared at each point in time. Cross-sectional analysis made use of multi-
variate techniques, including hierarchal cluster analysis (Euclidian distance and Ward linkage)
and multi-level principal component analysis (ML–PCA) [32]. Univariate approaches
included determining Wilcoxon signed-rank test (WRT) p-values and associated effect size, as
well as fold change (FC) values.
Next, statistical analysis focused on the metabolic perturbations that result from the con-
sumption of alcohol as measured in time. Through the application of a combination of statisti-
cal methods, and using time 0 as a reference point, or control group, a shortlist of significantly
perturbed NMR spectral bins was compiled and quantified from the “alcohol plus vehicle”
intervention data for biological interpretation. This list of important bins was extended
through the inclusion of metabolites that were well presented in the spectra, although they did
not contribute significantly to the statistical differentiation within the “alcohol plus vehicle”
consumption profiles.
Lastly, the effect of NAD supplementation was of interest. In order to evaluate this interven-
tion, a select list of biologically relevant metabolites was modelled across the time period and
across all four interventions using a two-way repeated measures analysis of variance (2-way
RM ANOVA) model. The significance of the differences was calculated using Greenhouse–
Geisser-corrected p-values. In addition, Wilcoxon signed-rank tests were performed to calcu-
late the significance of the differences between selected pairs of measurements.
Results
An example of a 1H-NMR spectrum (10.00 to 0.00 ppm), generated from the analysis of a rep-
resentative experimental sample collected one hour following the “alcohol plus vehicle” inter-
vention, is shown in Fig 1A, together with enlargements of four sections of the spectrum to
further illustrate some detail (Fig 1B–1E).
The dominating peaks in Fig 1A were from ethanol (due to the alcohol consumption), hip-
puric acid (the biotransformation product of benzoic acid, derived from the gut microbiome
and present in the vehicle used in all the interventions, as well as observed in a moderate red
wine nutritional study) [23], creatinine (a normal constituent of urine), and trimethylamine-
N-oxide (TMAO), a known osmolyte and protein stabilizer. Most notable was the presence of
an exceedingly complex area, approximately between 3.60 and 3.90 ppm (Fig 1B). Interpreta-
tion of this region is particularly difficult, since it may contain overlapping resonances from
several metabolites. The strong signals observed at 3.60–3.69, 3.73, 3.74–3.80 and 3.85 ppm
were suggestive of sorbitol in the urine, following alcohol consumption. This suggestion was
confirmed by comparing the spectra obtained through two-dimensional (2D) correlation spec-
troscopy (COSY) analysis of an experimental sample, obtained one hour after alcohol con-
sumption, and a sample containing sorbitol as a standard (Fig 2).
Next, an area with several related amines or amine derivatives is shown in Fig 1C, while Fig
1D indicates the presence of hypoxanthine (an intermediate in the catabolism of purines
towards uric acid) and indoxyl sulphate (a biotransformation product of tryptophan). Finally,
Fig 1E indicates the presence of ethanol itself, as well as the lactic acid doublet (1.33 ppm), the
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main known marker of lactic acidosis, and one of the primary effects of acute alcohol
consumption.
Spectral analysis of the representative sample gives a clear indication of the important
metabolites present in urine following alcohol consumption (Fig 1), but no information on the
underlying dynamic effects following the consumption. The next step was therefore to deter-
mine the time-dependent impact of the consumption of a single, large dose of alcohol. Statisti-
cal analyses of the data obtained from the experimental samples from the “vehicle only” and
“alcohol plus vehicle” interventions provide such information, and are illustrated in Fig 3. The
NMR spectra generated were dominated by the presence of hippuric acid (see [3]). Exclusion
of hippuric acid from the data set, however, did not significantly affect the relevant informa-
tion on alcohol consumption.
1.350 1.300 1.250 1.200 1.150
LA
EtOH
e
8.00 7.75 ppm
HX
IS IS
d
3.00 2.90 2.80 2.70 2.60 2.50
DMG
TMA
MA
CA
DMF DMF
CTc
3.900 3.800 3.700 3.600 ppm
GLY
SO
CT
b
10.00 7.50 5.00 2.50 0.00 ppm
HA
Cr
TMAO
HA
SA
a
Fig 1. Representative 1H-NMR spectrum of urine collected one hour following the “alcohol plus vehicle” intervention. EtOH = ethanol (1.18 t,
3.64 q); LA = lactic acid (1.33 d, 4.12 q); SA = succinic acid (2.41 s); TMAO = trimethylamine-N-oxide (3.27 s); CA = citric acid (2.61 AB);
MA = methylamine (2.61 s); TMA = trimethylamine (2.90 s); DMG = N,N-dimethylglycine (2.93 s); DMF = N,N-dimethylformamide (2.87 s, 3.02
s); CT = creatine (3.04 s, 3.93 s); GLY = glycine (3.57 s); SO = sorbitol (3.60–3.69 m, 3.73 d, 3.74–3.80 m, 3.82 d, 3.85 m); IS = indoxyl sulphate (7.51
d, 7.70 d); HX = hypoxanthine (8.20 d); HA = hippuric acid (3.97 d, 7.56 tt, 7.64 tt, 7.84 dd); Cr = creatinine (3.05 s, 4.06 s). [Not observed in the
present spectrum: fumaric acid (6.52 s) and 3-hydroxybutyric acid (1.20 d, 2.36 m, 4.15 m)].
https://doi.org/10.1371/journal.pone.0196850.g001
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Fig 3A and 3D (time 0) showed no group separation prior to vehicle or alcohol consump-
tion. It did, however, become apparent that one individual may have used an exogenous sub-
stance on the day of his “vehicle only” intervention experiment, which completely separated
this person from all others in the group (indicated as a red square in Fig 3A). This rendered
the data from this individual unfit for analysis, producing the final number of 20 cases used for
further analysis. The bin profiles obtained two hours after the “vehicle only” and “alcohol plus
vehicle” interventions clearly indicated group differences in the unsupervised analyses due to
the addition of alcohol (Fig 3B and 3E). The Volcano plot from data collected one hour after
alcohol consumption revealed a larger number of bins with significant up- and down-regu-
lated values (p 0.05 and │FC│ 2) relative to the number of bins from data collected one
hour after vehicle consumption (data not shown). This number of significant bins increased to
at least 58 out of the 289 bins (20%) two hours following consumption (Fig 3H). The number
of these bins progressively decreased 3 and 4 hours after consumption, becoming only 13 bins
after 4 hours that differed significantly between the two interventions (Fig 3I).
Given this marked effect, the next set of analyses were performed to identify and rank the
bins most affected by the consumption of alcohol using time 0 as a point of reference. Bins
3.900
3.800
3.700
3.600
3.500
3.900 3.800 3.700 3.600 3.500
b
3.900 3.800 3.700 3.600 3.500
a
Fig 2. Confirmation of sorbitol annotation. (a) 1D 1H-NMR of a representative urine sample collected one hour after alcohol consumption,
zoomed into the 3.50–3.90 ppm region (black), compared to the pure compound spectrum of sorbitol (blue). (b) Correlating 2D 1H-NMR COSY,
confirming the sorbitol annotation based upon proton correlation.
https://doi.org/10.1371/journal.pone.0196850.g002
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were shortlisted if they differed significantly within the “alcohol plus vehicle” intervention at
any point in time (relative to time 0) based on a significant WRT p-value 0.05 and |FC| 2.
This shortlist of bins was linked to a set of metabolites and quantified. This list, including only
the most perturbed metabolites, was then extended through the inclusion of metabolites which
were well presented in the spectra, but did not contribute significantly to the statistical differ-
entiation within the “alcohol plus vehicle” consumption profiles. Quantified uric acid data
(not identified by NMR analysis, but determined individually for each urine sample) was also
added to this final shortlist of 13 important metabolites. The concentrations of these 14 metab-
olites, at all five time points related to the “alcohol plus vehicle” intervention, are given in
Table 2, together with the relevant summary statistics, determined one (early effect) and four
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https://doi.org/10.1371/journal.pone.0196850.g003
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(late effect) hours after alcohol consumption. Time –1 is not included in Table 2 since it
reflects the past several hours prior to the intervention, and is not related to the “alcohol plus
vehicle” intake. The purpose of Table 2 was then to rank metabolites for biological interpreta-
tion of the consequences of the intervention.
The data summarized in Table 2 indicate that seven metabolites (ethanol, hypoxanthine,
indoxyl sulphate, lactic acid, methylamine, sorbitol and TMAO) were significantly up-regu-
lated (p 0.05) in the first hour following alcohol consumption. Five of these metabolites (eth-
anol, hypoxanthine, lactic acid, sorbitol and TMAO) remained up-regulated at every time
point up to time 4 after alcohol consumption, although less significantly so (p 0.05) than
after the first hour. This observation illustrates a general characteristic of metabolic profiling,
Table 2. Quantified data of important metabolites following alcohol consumption.
Variable Time 0 vs Time 1 (early effect) Time 0 Time 1 Time 2 Time 3 Time 4 Time 0 vs Time 4 (late effect)
WRT p-value WRT Effect Size Mean Mean Mean Mean Mean WRT p-value WRT Effect Size
[BH Adjusted p-
value]
[FC] [SD] [SD] [SD] [SD] [SD] [BH Adjusted p-
value]
[FC]
DMF (N,N-dimethylformamide) 0.057 0.301 15.98 16.58 15.64 16.01 17.12 0.017 0.378
[0.079] [+1.038] [2.292] [2.613] [2.795] [2.308] [2.699] [0.047] [+1.071]
DMG (N,N-dimethylglycine) 0.052 0.307 8.472 9.656 9.190 8.168 8.438 1.000 0.000
[0.079] [+1.140] [7.965] [10.02] [9.230] [7.640] [7.274] [1.000] [–1.004]
Ethanol <0.0001 0.620 0.000 1389 6448 3440 1912 <0.0001 0.620
[0.0004] [> +100] [0.000] [1556] [2673] [1984] [1250] [0.001] [> +100]
Glycine 0.044 0.319 160.2 183.4 151.4 146.6 158.3 0.601 0.083
[0.077] [+1.145] [84.90] [86.26] [44.68] [50.45] [56.11] [0.701] [–1.012]
Hippuric acid 0.313 0.159 220.4 380.2 87.66 138.1 178.9 0.100 0.260
[0.313] [+1.725] [217.2] [393.7] [124.4] [344.7] [333.7] [0.156] [–1.232]
Hypoxanthine <0.0001 0.620 9.604 78.63 29.82 14.44 12.48 0.044 0.319
[0.0004] [+8.187] [7.029] [45.97] [14.99] [5.716] [5.191] [0.077] [+1.299]
Indoxyl sulphate 0.002 0.490 24.30 27.86 24.87 21.51 22.87 0.794 0.041
[0.005] [+1.147] [10.29] [13.42] [16.04] [14.25] [11.19] [0.855] [–1.063]
Lactic acid 0.001 0.508 70.90 179.9 92.74 75.96 72.79 0.006 0.431
[0.004] [+2.537] [61.39] [274.8] [19.59] [14.04] [16.26] [0.022] [+1.027]
Methylamine 0.006 0.431 4.556 5.282 5.937 5.186 5.059 0.033 0.336
[0.013] [+1.159] [2.146] [2.477] [2.256] [2.380] [2.263] [0.073] [+1.110]
Sorbitol <0.0001 0.620 0.000 653.2 852.8 426.2 289.0 0.000 0.614
[0.0004] [> +100] [0.000] [462.0] [625.7] [331.6] [253.3] [0.001] [> +100]
Taurine 0.062 0.295 100.6 108.2 109.7 113.5 118.7 0.006 0.437
[0.079] [+1.076] [29.71] [32.54] [29.86] [37.45] [36.49] [0.022] [+1.180]
TMAO (trimethylamine N-
oxide)
0.002 0.502 51.18 58.32 60.31 62.45 62.00 0.037 0.331
[0.004] [+1.139] [23.90] [25.48] [29.26] [35.68] [32.48] [0.073] [+1.211]
Trimethylamine 0.100 0.260 1.753 1.987 1.763 1.654 1.615 0.167 0.218
[0.117] [+1.133] [1.229] [1.657] [1.680] [1.578] [1.436] [0.234] [–1.085]
Uric acid 0.247 0.183 0.963 0.713 0.336 0.487 0.743 0.211 0.198
[0.266] [–1.351] [0.760] [0.279] [0.168] [0.243] [0.566] [0.269] [–1.296]
All quantified values, except those for uric acid (expressed as mmol/L), are from NMR-determined urine analyses, and are expressed as μmol metabolite/mmol
creatinine. WRT p-values are based on the comparison of the respective metabolite concentrations relative to time 0 for time 1 and time 4 of the “alcohol plus vehicle”
intervention. P-values adjusted for multiple testing (14 tests in total) are also reported based on the Benjamini & Hochberg (BH) approach for controlling the rate of
false discoveries. Positive and negative fold change values indicate up- and down-regulation of metabolites, relative to time 0, respectively.
https://doi.org/10.1371/journal.pone.0196850.t002
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well known in the area of inherited diseases: serial examinations of urinary metabolites show
that the amounts of these acids excreted varies greatly in time following a perturbation, mostly
due to different metabolic consequences related to the perturbation. The uric acid excretion
profile observed in this study further emphasizes this characteristic. The profile of urinary uric
acid differed distinctly from those of the other metabolites mentioned—its concentration
decreased from time 0, and became significantly reduced 2 and 3 hours after alcohol consump-
tion (p 0.05 relative to time 0). Thereafter, its concentration steadily increased to near its
initial level after 4 hours. Three other metabolites, DMF, taurine and glycine, became signifi-
cantly up-regulated at some stage following alcohol consumption. The up-regulation of two
metabolites, DMG and trimethylamine, was not significant at any time point relative to time 0
following the intervention. The excretion profile of hippuric acid followed the same trend as
previously reported for the “vehicle only” intervention [3].
These mean values of the metabolites over time indicate the dynamic aspect following alco-
hol consumption, but do not reflect individual responses towards the intervention. Inter-indi-
vidual variation has already been well established even for consumption of only the vehicle
used in this study [3], and therefore, this aspect is not discussed in detail here. Instead, focus
was placed on the individual, as well as the group, concentration changes of the five important
metabolites that were significantly up-regulated during the whole time period following alco-
hol consumption, as well as on the concentration changes of uric acid, owing to its unique
excretion profile.
Fig 4 displays subplots as a set of solid lines (and one dotted line) representing the observa-
tions from the 20 individuals across 5 time points for each of the six metabolites shown to be
significantly up-regulated in Table 2. The black dashed lines represent one potential LOWESS
(locally weighted scatterplot smoothing) regression for each metabolite against time using a
bi-weight kernel. Most individuals excreted a limited amount of ethanol in their urine one
hour after alcohol consumption, and, generally, ethanol excretion peaked two hours following
alcohol consumption (Fig 4A). Likewise, most individuals showed a distinct excretion of the
osmolyte sorbitol one hour after alcohol consumption (Fig 4B), albeit at different concentra-
tions. The LOWESS regression curve for sorbitol, however, peaked at 2 hours for the group as
a whole. The concentration of TMAO, another osmolyte, increased significantly from time 0
(Fig 4C), reaching a plateau at 3 hours. Its final concentration was, however, still higher
(p = 0.037) than the baseline value at time 0.
The next observations from Fig 4 are closely associated with the known alcohol-induced
disturbance of the NAD+:NADH ratio in hepatocytes. The excretion of lactic acid for the
group peaked at 2 hours, but 4 individuals showed an early and excessive response one hour
after alcohol consumption (Fig 4D). The profile of the LOWESS regression curve for hypoxan-
thine (Fig 4E) distinctly peaked one hour following alcohol consumption. Two of the early
high lactic acid responders showed similar, high hypoxanthine excretion profiles. The general
profile of uric acid excretion (Fig 4F) was a mirror image of that of hypoxanthine, indicating
the NAD+-dependence of its formation through dehydrogenation of hypoxanthine (catalysed
by xanthine dehydrogenase; EC 1.17.1.4).
Most individuals followed the general trend indicated by the LOWESS regression line,
although one showed an early excretion of ethanol following alcohol consumption (shown as a
red dotted line in Fig 4). Compared to the group, this individual also presented with a high
excretion of sorbitol and TMAO, peaking at one hour, an early and extremely high lactic acid
excretion, high excretion of hypoxanthine, but comparable excretion of uric acid. Since this
person did not present as an outlier, we attribute this variation to the unique response of this
individual to alcohol consumption. Diversity in the excretion profiles of the individuals within
the group, emphasized by the one highlighted person, clearly illustrates the importance of
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inter-individuality, previously described for the consumption of only the vehicle [3]. Taken
together, the combination of observations summarized in Table 2 and illustrated in Fig 4 indi-
cate that the cases themselves are a noteworthy source of variation, while the group response
provided the opportunity for the development of a holistic model of the effect of acute alcohol
consumption.
Finally, the ingestion of one tablet of an NAD-containing supplement, proposed to poten-
tially counteract the effects of alcohol consumption, did not show a notable effect if taken one
hour before the alcohol dose. To illustrate this, the complete design of this study (that is, four
interventions measured over 6 time points) was modelled for quantified hypoxanthine and
sorbitol, using a 2-way RM ANOVA model based on log transformed data to improve normal-
ity. Reported in the graphs are the Greenhouse–Geisser-corrected p-values for the main effects
(where significant), as well as specific comparisons based on the Wilcoxon signed-rank tests
(Section A.3.3 in S1 File provides more details on this analysis). These two metabolites were
selected based on the NAD+-dependence of their catabolism (hypoxanthine! xanthine!
uric acid, both reactions catalysed by xanthine dehydrogenase; and sorbitol! fructose, cata-
lysed by sorbitol dehydrogenase (SD; EC 1.1.1.14), respectively). Fig 5 provides a brief over-
view of the information extracted from this model.
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Fig 5A and 5C indicate a significant difference in the average levels of hypoxanthine and
sorbitol, respectively, between the interventions including and excluding alcohol, as well as in
time between the interventions including alcohol. Fig 5B and 5D, likewise, indicate a signifi-
cant difference in the average change in the levels of hypoxanthine and sorbitol across the time
period between the four interventions. All the results from this approach therefore arrive at
the same conclusion—the observed differences were mainly attributable to the consumption
of alcohol. For sorbitol, the differences were only significant when comparing the two inter-
ventions involving alcohol with the two not involving alcohol. No significant differences were
observed between the two interventions not involving alcohol, nor between the two interven-
tions involving alcohol. For hypoxanthine, significant differences were observed between the
“alcohol plus vehicle” and the “vehicle plus alcohol and NAD” interventions at 2 and 3 hours
after consumption, with significance on the average levels at 2 and 4 hours, respectively.
Although alcohol consumption caused increased hypoxanthine excretion, it appears that the
addition of NAD resulted in even higher amounts of hypoxanthine being excreted. These
results indicate that NAD, as used in this study, might potentially have an effect in the later
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phases following alcohol consumption, but, as a whole, do not justify its application as a sup-
plement to counteract the effects of alcohol consumption.
Discussion
It is known that three mechanisms for ethanol metabolism may be operative in the liver: (1)
the ADH-pathway in the cytosol; (2) the microsomal ethanol oxidizing system (MEOS) of the
endoplasmic reticulum; and (3) the catalase mechanism, located in peroxisomes [33]. In the
ADH-pathway, ethanol is converted to acetaldehyde and acetate in two consecutive dehydro-
genase reactions, both dependent on NAD+. During both of these reactions NAD+ is reduced,
generating excess amounts of NADH. Following acute alcohol consumption, NAD+ depletion,
and the subsequent excessive production of reducing equivalents, greatly perturb the hepato-
cyte redox homeostasis. This perturbation is known, but, through the present NMR metabolo-
mics study, new insights were revealed—illustrated in Fig 6. This figure proposes a model that
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outlines three essential disturbances that occur following acute alcohol consumption—up-reg-
ulated lactic acid metabolism, down-regulated purine catabolism and osmoregulation.
First, up-regulation of lactic acid is coupled to the high hepatic NADH:NAD+ ratio (due to
ADH- and ALDH-catalysed ethanol catabolism), which diverts pyruvic acid metabolism
towards lactic acid, and subsequently inhibits gluconeogenesis. During low or chronic alcohol
consumption, excess lactic acid is exported from the liver to peripheral tissues, where NADH
levels are lower, and lactic acid may be reconverted to pyruvic acid for metabolic needs. Dur-
ing acute alcohol consumption, however, aerobic oxidation (that is, the Krebs cycle, the respi-
ratory chain and oxidative phosphorylation) is known to be inhibited [5,6], which was
indicated in our study by the increased levels of fumaric acid (not observed in all experimental
subjects) and succinic acid. Similarly, due to the high hepatic NADH:NAD+ ratio and inhibi-
tion of the Krebs cycle, ethanol-derived acetyl-CoA may be converted to acetoacetic acid and
3-ketobutyric acid, as seen in the urine samples from some of our experimental subjects. The
values of these metabolites were, however, generally too low to enable their quantification. A
noteworthy observation was that a few of the experimental subjects showed excessive urinary
lactic acid excretion shortly after alcohol intake (Fig 4D), whereas the excretion of the majority
of the subjects peaked at two hours following alcohol consumption. These observations are yet
a further example of the individual differences in coping with the consumed alcohol. The com-
mon paradigm is that variation in response to alcohol consumption is genetically controlled,
and is suspected to cause a predisposition towards the development of alcohol-induced liver
disease and alcoholism [34]. Furthermore, we observed that the mean value of urinary lactic
acid peaked one hour after alcohol consumption (increasing roughly 2.5 times from 70.90 mM
to 179.9 mM (p = 0.001)) and declined to a near normal value three hours after consumption
(75.90 mM). This is comparable to the decreased lactic acid levels measured in liver and serum
samples from rats, decapitated three hours following treatment with a single intragastric dose
of ethanol [18].
Second, hypoxanthine, an intermediate in purine catabolism and a precursor of uric acid,
appeared to be an important indicator of acute alcohol consumption (Fig 4E). This is in agree-
ment with the increased hypoxanthine observed in patients suffering from alcohol- and hepati-
tis B-induced cirrhosis [11], and in those listed with stearamide as biomarker for hepatic
cirrhosis [17]. In addition, several intravenous ethanol infusion, and related, studies on purine
metabolism in humans (reviewed in [35]) indicated that many factors affect this metabolic
pathway—daily drinking habits; the type of alcoholic beverages; exercise; and, ultimately,
ALDH polymorphisms, are all important contributing factors. Increased AMP following alco-
hol consumption seems to be the important metabolic departure point in reflecting on purine
catabolism—alcohol-induced diminished ATP production via glycolysis [36] and increased
adenine nucleotide turnover [37], contribute towards increased ADP levels, and its increased
conversion to AMP. Additionally, during the ADH- and ALDH-catalysed degradation of etha-
nol, two equivalents of ATP are consumed and two equivalents of AMP are produced for each
equivalent of ethanol converted to acetyl-CoA [38]. All these perturbations lead to a consider-
able alcohol-induced increase in AMP, which is then catabolised and reflected in the hypoxan-
thine and, ultimately, uric acid profiles. Hyperuricaemia, gout and increased urinary uric acid
excretion, accompanied by raised urinary hypoxanthine and xanthine concentrations, are
accepted indicators of chronic alcohol consumption, although excretion of hypoxanthine was
shown to be lower than that of xanthine in regular drinkers [39]. In our study, we observed a
highly significant increase (Table 2: p 0.0001; FC = +8.187) in hypoxanthine excretion in all
20 cases studies, which peaked at one hour after alcohol consumption in 18 of the cases, and at
2 hours in the other two cases (Fig 4E). The general pattern of the urinary excretion of uric
acid (Fig 4F) presents as a mirror image to that of hypoxanthine, initially decreasing and then
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returning to near its starting concentration. We relate these observations to the alcohol-
induced perturbed hepatic redox state—depleted NAD+, the cofactor for xanthine dehydroge-
nase, interrupts the purine catabolic pathway, decreasing the conversions of hypoxanthine to
xanthine, and xanthine to uric acid. However, as the NADH:NAD+ ratio normalizes, these
reactions can once again take place, resulting in the catabolism of hypoxanthine to produce
uric acid. It should, however, be noted that lactic acid, which is highly increased following
alcohol consumption, competitively inhibits the clearance of uric acid through the renal proxi-
mal tubule [40], which further supports the observed initial decrease in uric acid excretion fol-
lowing alcohol consumption. Thus, while hyperuricaemia is an accepted marker of regular
and chronic alcohol consumption, increased excretion of hypoxanthine may possibly act as an
indicator of acute alcohol consumption.
Third, of notable interest, was the observation of the increased urinary excretion of sorbitol
following ethanol consumption, which is not listed in the review on global metabolic profiling
studies on alcohol-related disorders, covering NMR, GC–MS and LC–MS approaches [17].
Sorbitol was not detected in any of the urine samples collected prior to any of the interventions
(normal reference value: 3.506 ± 2.24 μmol/mmol creatinine) [25]. Its excretion, however,
increased rapidly in most individuals following alcohol consumption (Fig 4B). Moreover, the
sorbitol excretion profile did not seem to be affected by the consumption of the NAD supple-
ment, taken prior to alcohol consumption (Fig 5C and 5D). Sorbitol is an organic osmolyte
present in all human cells, and, together with other osmolytes, reaches very high concentra-
tions (in the millimolar range) in the cytosol. In human cells, the osmolytes are classified into
three groups [41]: (1) amino acids and their derivatives (including taurine); (2) methylamines
(including TMAO); and (3) polyols (including sorbitol). Osmolytes play key roles as cytopro-
tectants, and in maintaining cell volume homeostasis [42]. They function as nonperturbing
solutes, which permits their accumulation to high levels and large shifts in their concentrations
without having deleterious effects on cellular structure and function [41]. These unique char-
acteristics of osmolytes opened several lines of thought regarding the perturbation of sorbitol
following acute alcohol consumption. Of these postulates, sorbitol synthesis and catabolism
(occurring in the polyol pathway), as well as its function in osmoregulation, are pertinent:
(1) The NADPH-dependent enzyme aldose reductase (AR; EC 1.1.1.21) catalyses the syn-
thesis of sorbitol from glucose. This reaction is highly operative under hyperglycaemic condi-
tions, such as in diabetes mellitus [43], when up to 30% of glucose is channelled into the AR-
catalysed polyol pathway. However, given the fasting state of the experimental subjects before
the “alcohol plus vehicle” intervention, and the increased anaerobic oxidation of glucose
towards lactic acid, it seems unlikely that sorbitol accumulation was due to the activation of
sorbitol synthesis. (2) The next step in the polyol pathway is the degradation of sorbitol to fruc-
tose, a reaction catalysed by the NAD+-dependent enzyme sorbitol dehydrogenase (SD). In
this study, sorbitol accumulation may be attributed to the alcohol-induced inhibition of its
catabolism—due to the metabolism of ethanol, the NAD+ required for the dehydrogenation of
sorbitol becomes depleted. Furthermore, significant down-regulation of SD has been observed
in a study on the changes of the cytoplasmic proteome in response to alcoholic hepatotoxicity
in rats [44], which lends support to this viewpoint. (3) Increased sorbitol as a consequence of
its role in osmoregulation, however, seems to be the preferred explanation for interpreting the
observed urinary excretion profile of sorbitol. Ethanol is both water and lipid soluble, which
renders it a membrane-permeable substance. Abnormal cell volume regulation significantly
contributes to the pathophysiology of several disorders, and cells respond to these changes by
importing, exporting, or synthesizing osmolytes to maintain volume homeostasis [45]. On an
experimental level, oedema/cell swelling could be induced by binge-simulated ethanol expo-
sure in slice cultures of the developing rat brain [46]. In a cell-to-medium flux study,
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hyperosmotically induced intracellular accumulation of sorbitol in renal epithelial cells showed
a greater than 150-fold increased efflux within five minutes after exposure to an isosmotic
medium. We thus speculate that the increased sorbitol excretion in our alcohol-exposed sub-
jects relates to ethanol-induced hepatocyte swelling, which is compensated for by sorbitol
release in order to maintain cellular volume homeostasis. Although less pronounced in this
study than that of sorbitol, perturbations of other osmolytes, such as TMAO and taurine
(observed in this study, see Table 2), should also be considered in the examination of osmolyte
responses.
In summary, we have described the urinary metabolite profile of healthy, young males fol-
lowing acute alcohol consumption as part of a designed intervention study. The complex
NMR spectral data, generated from individuals participating in a time-dependent cross-over
study, could be resolved sufficiently through the application of univariate and multivariate sta-
tistical analyses. This approach provided a novel method for the analysis and understanding of
the complex metabolomics data that were produced due to acute alcohol consumption. We
indicate that NAD+ depletion, and the production of an excessive amount of reducing equiva-
lents, greatly perturb the hepatocyte redox homeostasis, resulting in metabolic disturbances, of
which urinary excretion of sorbitol is novel. We postulate that sorbitol is a marker of a cell vol-
ume regulatory response to ethanol-induced hepatocyte swelling. This may have a wider sig-
nificance related to brain oedema-induced neurodegenerative damage following chronic binge
alcohol exposure [46,47].
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